SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                               ------------------

                               AMENDMENT NO. 2 TO

                                   FORM 8-K/A

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                               ------------------


                          Date of Report: May 20, 2003

                          ALTRIMEGA HEALTH CORPORATION
                          ----------------------------
               (Exact Name of Registrant as Specified in Charter)

           NEVADA                       0-29057                   87-0631750
           ------                                                 ----------
(State or other jurisdiction          (Commission               (IRS Employer
     of incorporation)               File Number)            Identification No.)


     4702 OLEANDER DRIVE, SUITE 200, MYRTLE BEACH, SC                  29577
         (Address of principal executive offices)                   (Zip code)

   Registrant's telephone number, including area code:            (843) 497-7028













ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

         On October 4, 2002,  Altrimega Health Corporation  ("Altrimega")  filed
with the Securities and Exchange  Commission on Amendment No. 1 to Form 8-K/A an
announcement  that  Altrimega had entered into a share  exchange  agreement with
Creative Holdings,  Inc., a South Carolina corporation.  Altrimega is filing the
financial  statements  required by Regulation S-X as a result of the merger with
this Amendment No. 2 to Form 8-K/A.

         (a) FINANCIAL STATEMENTS.

Altrimega Financial Statements attached.

         (b) PRO FORMA FINANCIAL INFORMATION.

Attached.

         (c) EXHIBITS.

None.

                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        ALTRIMEGA HEALTH CORPORATION


Date: May 20, 2003                      By: /S/ JOHN GANDY
                                            --------------
                                        Name: John Gandy
                                        Its:  President and Chief Executive
                                              Officer









                                       2




                          ALTRIMEGA HEALTH CORPORATION

           UNAUDITED CONDENSED COMBINED PRO FORMA FINANCIAL STATEMENTS

The following unaudited condensed combining pro forma financial statements ("the
pro forma  combining  financial  statements")  and  explanatory  notes have been
prepared and give effect to the Share Exchange Agreement ("Exchange  Agreement")
between Altrimega Health  Corporation and Creative  Holdings,  Inc. as a reverse
acquisition and has been accounted for as a recapitalization of Altrimega Health
Corporation. Creative Holdings, Inc. is the acquiring enterprise for purposes of
accounting for the reverse acquisition, with Altrimega Health Corporation as the
legal entity for reporting purposes.  The Exchange Agreement was entered into as
of August 15, 2002 and was subsequently amended on September 2, 2002. Since none
of the acquisition transactions had taken place as of the dates of the combining
proforma financial  statements,  each of the respective  entities has been shown
separately.

Currently,  the year ends for  Creative  Holdings,  Inc.  and  Altrimega  Health
Corporation  are December 31. No amounts  have been  presented  for December 31,
2001 pro forma combining financial statements for Creative Holdings,  Inc. since
it was not incorporated until July 3, 2002. The accompanying pro forma combining
financial  statements are presented with the nine month period ending  September
30, 2002.

In  accordance  with  Article 11 of  Regulation  S-X under the  Securities  Act,
unaudited condensed pro forma combining balance sheets ("the pro forma combining
balance sheets") as of September 30, 2002, and unaudited condensed combining pro
forma  statements  of  operations  ("the  pro  forma  combining   statements  of
operations")  for the nine months ended  September 30, 2002, and the period from
inception on July 3, 2002 through  September  30,  2002,  have been  prepared to
reflect, for accounting purposes, the acquisition by Creative Holdings,  Inc. of
Altrimega Health  Corporation.  For both the pro forma combining  balance sheets
and the pro forma  combining  statements  of  operations,  the  number of common
shares gives effect to the share exchange of Altrimega  Health  Corporation  for
Creative  Holdings,  Inc.  as if  the  reorganization  had  taken  place  at the
beginning of the periods presented.

The  accompanying  pro forma combining  financial  statements have been prepared
based upon the historical  financial  statements of the entities.  The pro forma
combining financial statements should be read in conjunction with the historical
financial statements and related notes thereto of each entity as of December 31,
2001 and  September  30,  2002,  and for the years and periods  then ended,  all
included  elsewhere in this Form 8-K/A and/or in previous  periodic filings with
the United States Securities and Exchange Commission.

The pro forma  combining  financial  statements  assume that the  reorganization
involving all of the companies had been completed for the periods presented. All
intercompany  activity  between the entities  during the periods  presented have
been eliminated in preparing the pro forma combining financial statements.

The pro forma  combining  financial  statements  are provided  for  illustrative
purposes only, and are not  necessarily  indicative of the operating  results or
financial  position  that would have  occurred  if the  reorganization  had been
consummated at the beginning of the periods or on the dates  indicated,  nor are
they  necessarily  indicative  of any  future  operating  results  or  financial
position of the combined entities.  The pro forma combining financial statements
do not include any adjustments related to any restructuring  charges or one-time
charges  which  may  result  from the  reorganization  or the  final  result  of
valuations of inventories,  property,  plant and equipment,  intangible  assets,
debt, and other obligations.


                                       3




                                      ALTRIMEGA HEALTH CORPORATION
                          UNAUDITED CONDENSED COMBINED PRO FORMA BALANCE SHEET

                                                                                             PRO FORMA
                                CREATIVE       ALTRIMEGA                                      COMBINED
                                HOLDINGS        HEALTH        CONTINUED                    CREATIVE AND
                                 AS OF          AS OF          HISTORICAL                     ALTRIMEGA
                              SEPTEMBER 30,  SEPTEMBER 30,   CREATIVE AND   PRO FORMA      SEPTEMBER 30,
                                 2002           2002           ALTRIMEGA    ADJUSTMENTS         2002
                              -------------  -------------   ------------  -----------     -------------
                                                                            
ASSETS

CURRENT ASSETS:
  Cash                        $         904  $         -     $        904  $       -       $        904
                              -------------  -------------   ------------  -----------     ------------
    Total Current Assets      $         904  $         -     $        904  $       -       $        904
                              -------------  -------------   ------------  -----------     ------------
OTHER ASSETS:
  Web Site Design                     1,084            -            1,084          -              1,084
  Investment in Subsidiary              -              -              -          3,200 (1)
                                                                                (3,200)(3)
                              -------------  -------------   ------------  -----------     ------------
    Total Other Assets                1,084            -            1,084          -              1,084
                              -------------  -------------   ------------  -----------     ------------
TOTAL ASSETS                  $       1,988  $         -     $      1,988  $       -       $      1,988
                              =============  =============   ============  ===========     ============

LIABILITIES AND STOCKHOLDERS'
  EQUITY (DEFICIT)

CURRENT LIABILITIES:
  Accounts payable            $         -    $      60,886   $     60,886  $    25,000 (4) $     85,886
  Accrued liabilities                    30            -               30          -                 30
  Notes payable                       2,000            -            2,000          -              2,000
                              -------------  -------------   ------------  -----------     ------------
    Total Current Liabiities            -           60,886   $     60,886  $    25,000 (4) $     85,886
                              -------------  -------------   ------------  -----------     ------------
    Total Liabilities                   -           60,886   $     60,886  $    25,000 (4) $     85,886
                              -------------  -------------   ------------  -----------     ------------
STOCKHOLDERS' EQUITY:
  Preferred stock                       -              -              -          1,000 (1)        1,000
  Common stock                        3,200         22,020         25,220       20,000 (1)
                                                                                (3,200)(3)
                                                                                                 42,020
  Additional paid-in capital         (1,200)       117,135        115,935      (17,800)(1)
                                                                              (200,041)(2)     (101,906)
  Accumulated deficit during
   the development stage                (42)      (200,041)      (200,083)     200,041 (2)
                                                                               (25,000)(4)      (25,042)
                              -------------  -------------   ------------  -----------     ------------
    Total Stockholders'
     Equity                           1,958        (60,886)       (58,928)     (25,000)         (83,928)
                              -------------  -------------   ------------  -----------     ------------
TOTAL LIABILITIES AND
 STOCKHOLDERS' EQUITY
 (DEFICIT)                    $       1,958  $         -     $      1,958  $       -       $      1,958
                              =============  =============   ============  ===========     ============


_______________________


(1)  To record  issuance  of  20,000,000  shares of common  stock and  1,000,000
     shares of preferred stock in exchange for all issued and outstanding shares
     of Creative per Share Exchange Agreement.

(2)  To eliminate deficit of Altrimega prior to Share Exchange Agreement.

(3)  To  eliminate  common stock of Creative and the  investment  in  subsidiary
     accounts.

(4)  To  record  estimated  costs  for  the  completion  of the  share  exchange
     agreement.

                                       4




                                      ALTRIMEGA HEALTH CORPORATION
                     UNAUDITED CONDENSED COMBINED PRO FORMA STATEMENT OF OPERATIONS
                                                                                             PRO FORMA
                                                                                              COMBINED
                                CREATIVE       ALTRIMEGA                                    CREATIVE AND
                                HOLDINGS        HEALTH                                        ALTRIMEGA
                                FOR THE      FOR THE NINE                                   FOR THE NINE
                              PERIOD ENDED   MONTHS ENDED      COMBINED                     MONTHS ENDED
                              SEPTEMBER 30,  SEPTEMBER 30,   CREATIVE AND    PRO FORMA      SEPTEMBER 30,
                                 2002           2002           ALTRIMEGA     ADJUSTMENTS         2002
                              -------------- -------------   -------------  ------------    -------------
                                                                             

Sales                         $         -    $         -     $        -     $       -       $        -

General and administrative
 expenses                                12         60,886    $     60,898       25,000 (1)
                                                                                (60,886)(2)       25,012
                              -------------- -------------   -------------  ------------    -------------
Loss from operations                    (12)       (60,886)       (60,898)       35,886          (25,012)
                              -------------- -------------   -------------  ------------    -------------
Other income (expense)                  (30)           -              (30)          -                (30)
                              -------------- -------------   -------------  ------------    -------------
Net loss                      $         (42) $     (60,886)  $    (60,928)  $    35,886     $    (25,042)
                              ============== ==============  =============  ============    =============
Basic loss per share                  (0.00)         (0.00)         (0.00)                         (0.00)
                              ============== ==============  =============                  =============
Weighted average shares
 outstanding                      3,200,000     22,020,000     25,220,000                     27,987,641 (3)
                              ============== ==============  =============                  =============


_____________________


(1)  To  record  estimated  costs  for  the  completion  of the  share  exchange
     agreement

(2)  To eliminate deficit of Altrimega prior to Share Exchange Agreement

(3)  Weighted  average  shares  outstanding  reflects  the  exchange of Creative
     Holdings, Inc. common stock for Altrimega Health Corporation common stock.

                                       5